Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Usana Health SciencesSTU:USJ +3.78%67 Interest Coverage is 57.70 as of Mar. 2026, which is 87% below its 10-year median of 457.86. GuruFocus rates STU:USJ with a GF Score™ of 67/100 and a GF Value™ of €35.51 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,516 Consumer Packaged Goods companies, Usana Health Sciences ranks better than 81.93% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Usana Health Sciences's
Operating Income
for the
three
months ended in Mar. 2026 was €12.0 Mil. Usana Health Sciences's Interest Expense for the
three
months ended in Mar. 2026 was €-0.2 Mil.
Usana Health Sciences's interest coverage for the quarter that ended in Mar. 2026 was 57.70.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Usana Health Sciences Inc has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Usana Health Sciences's Interest Coverage or its related term are showing as below:
STU:USJ'
s Interest Coverage Range Over the Past 10 Years
Min: 60.41 Med: 457.86 Max: 5232.03
Current: 73.12
STU:USJ's Interest Coverage is ranked better than 81.93% of 1516
companies
in the Consumer Packaged Goods industry
Industry Median: 8.605
vs STU:USJ: 73.12
Usana Health Sciences (STU:USJ) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Usana Health Sciences Interest Coverage Related Terms
Usana Health Sciences Interest Coverage Historical Data
* Premium members only.
The historical data trend for Usana Health Sciences's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
STU:USJ vs NATR, ENHA, BYND: Interest Coverage Comparison
For the Packaged Foods subindustry, Usana Health Sciences's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Usana Health Sciences Interest Coverage vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Usana Health Sciences's Interest Coverage falls into.
Usana Health Sciences Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Usana Health Sciences (STU:USJ) has a Interest Coverage of 57.70 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Usana Health Sciences and its competitors. This is 87% below median its historical median of 457.86. Over the past decade, Usana Health Sciences' Interest Coverage has ranged from 60.41 to 5,232.03. According to the industry distribution chart, Usana Health Sciences ranks #274 out of 1516 companies in the Consumer Packaged Goods industry, placing it in the top 18.1%.
Is Usana Health Sciences' Interest Coverage too high?
Usana Health Sciences' current Interest Coverage of 57.70 is 87% below median its 10-year median of 457.86. Over the past 10 years, this metric has ranged from a low of 60.41 to a high of 5,232.03. The Consumer Packaged Goods industry median Interest Coverage is 8.61. Usana Health Sciences' value of 57.70 is 570.5% above this industry median. Based on the distribution chart, Usana Health Sciences ranks #274 out of 1516 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Usana Health Sciences has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Usana Health Sciences' Interest Coverage compare to NATR and ENHA?
According to the Consumer Packaged Goods industry distribution chart, Usana Health Sciences ranks #274 out of 1516 companies for Interest Coverage. This places Usana Health Sciences in the top 18% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 8.61. Usana Health Sciences' value of 57.70 is 570.5% above this benchmark. Historically, Usana Health Sciences' own Interest Coverage has ranged from 60.41 to 5,232.03 over the past decade. While the company's 10-year median is 457.86 vs. the industry median of 8.61, Usana Health Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.61, based on 1,516 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Usana Health Sciences's current Interest Coverage of 57.70 is 570.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Usana Health Sciences and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Usana Health Sciences's current Interest Coverage is 57.70, which is 87% below median its own 10-year median of 457.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Usana Health Sciences stock overvalued right now?
Based on GuruFocus' analysis, Usana Health Sciences (STU:USJ) is currently considered Possible Value Trap. The stock's GF Value™ is €35.51, compared to a current price of €19.20 — trading 45.9% below its estimated fair value. The current Interest Coverage is 57.70, which is 87% below median its 10-year median of 457.86 and 570.5% above the Consumer Packaged Goods industry median of 8.61. Usana Health Sciences' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Usana Health Sciences (STU:USJ), the current Interest Coverage is 57.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Usana Health Sciences (STU:USJ) Overvalued in 2026?
Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued.
The current stock price of €19.20 is trading 45.9% below its estimated GF Value™ of €35.51.
GuruFocus considers Usana Health Sciences to be Possible Value Trap.
Key valuation signals for STU:USJ:
Interest Coverage: 57.70 (87% below median its 10-year median of 457.86)
GF Value™: €35.51 vs. price of €19.20 (45.9% below fair value)
Industry Position: 570.5% above the Consumer Packaged Goods median (#274 of 1516)
No single metric tells the full story. See the STU:USJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
67GF Score
Get the complete analysis for STU:USJ
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:USJ has been successfully added to your 
